MP49-05 INTRAVESICAL NERVE GROWTH FACTOR-TARGETING THERAPY USING LIPOSOME-CONJUGATED ANTISENSE IN RATS WITH STRESS-INDUCED BLADDER HYPERSENSITIVITY. (May 2022)